Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-15

Clinical Trial Update: Caspase Inhibition in Islet Transplantation [Phase 1, Phase 2]

View source ↗

Summary

The document reports a Phase 1/Phase 2 clinical trial update on caspase inhibition in islet transplantation for diabetes, with the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Diabetes | Phase 1, Phase 2 | Status: COMPLETED